Heading to Phoenix for #HFSA2026? Visit Alleviant Medical at tabletop exhibit #604 to connect with our team. Learn more throughout the meeting about the ALLAY-HF and ALLAY-HFrEF pivotal trials evaluating atrial shunting across the ejection fraction spectrum. #HFSA #HeartFailure #ALLAYHF #ALLAYHFrEF #AtrialShunt

Recent moments from across the global #ALLAYHF network. Thank you to our participating sites for their continued dedication to advancing heart failure research and supporting the progress of the ALLAY-HF trial. #AtrialShunt #HeartFailure #InterventionalCardiology #StructuralHeart #InterventionalHeartFailure #ClinicalResearch #HFpEF #Cardiology #HeartFailureAwareness

This #WorldHeartDay, we join the global cardiovascular community in raising awareness and supporting action to improve heart health. ❤️ At Alleviant Medical, we’re advancing research across the full spectrum of heart failure through the ALLAY-HF and ALLAY-HFrEF clinical trials. Learn more: alleviantmedical.com/hf-shun… #DontMissABeat #HeartFailure #HFpEF #HFrEF

Thank you to our #ALLAYHF sites with recent randomizations. Your dedication to heart failure research through the summer months is appreciated! #AtrialShunt #HeartFailure #interventionalcardiology #StructuralHeart #InterventionalHeartFailure #ClinicalResearch #HFpEF #Cardiology #HeartFailureAwareness

Congratulations to PI Dr. Michael Fong and the research team at Keck Medicine of USC (@KeckMedicineUSC) on their first #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology

Congratulations to PI Dr. Daniel Pauly and the research team at Carilion Clinic (@CarilionClinic) on their latest #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology

Congratulations to PI Dr. Chowdhury Ahsan and the research team at UMC Hospital (@UMCSN) on their first #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology

Congratulations to PI Dr. Rohit Bhatheja MD and the research team at AdventHealth (@AdventHealth) on their fifth #ALLAYHF randomization! #atrialshunt #HFpEF #heartfailure #structuralheart #interventionalcardiology

We were pleased to bring together investigators and clinical leaders at the @escardio #ESCCongress this weekend for a focused discussion on the ALLAY-HF and ALLAY-HFrEF global pivotal trial programs. Together, we’re advancing innovation across the full spectrum of heart failure. Thank you to the physicians who shared their perspectives, expertise and continued partnership in advancing heart failure research. #ALLAYHF #ALLAYHFrEF #atrialshunt #HFpEF #HFrEF #heartfailure #structuralheart #interventionalcardiology #interventionalheartfailure #clinicalresearch

Congratulations to PI Dr. Josep Rodés-Cabau and the research team at Institut Universitaire De Cardiologie Et De Pneumologie de Québec (@IUCPQ) on their recent #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology

Congrats to PI Dr. Mark Lawrence and the team at Hendrick Health (@HendrickHealth) on their first #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology

Congratulations to PI Dr. Donald Cross and the research team at Waco Cardiology (@WacoCardiologya) on their first #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology

Early clinical outcomes: Dr. Brian Potter discusses the experience of a patient who participated in an early feasibility study of the Alleviant investigational device for chronic heart failure. The investigational Alleviant technology is currently being evaluated in the ALLAY-HF and ALLAY-HFrEF clinical trials. To learn more, visit: alleviantmedical.com CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only. #HeartFailure #InterventionalCardiology #StructuralHeart #InterventionalHeartFailure #ClinicalResearch #HFpEF #HFrEF #Cardiology #HeartFailureAwareness #Epeeps

Early clinical outcomes: Dr. Rob Gooley discusses the experience of a patient who participated in an early feasibility study of the Alleviant investigational device for chronic heart failure. The Alleviant device is currently being evaluated in the ALLAY-HF and ALLAY-HFrEF clinical trials. To learn more, visit: alleviantmedical.com CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only. #HeartFailure #InterventionalCardiology #StructuralHeart #InterventionalHeartFailure #ClinicalResearch #HFpEF #HFrEF #Cardiology #HeartFailureAwareness #Epeeps

The Alleviant System is an investigational device currently being studied in patients suffering from heart failure who are symptomatic despite currently available therapies. The device is designed to create an interatrial shunt through a minimally invasive procedure without requiring open heart surgery. Watch to learn more about the minimally invasive technology being evaluated in the ALLAY-HF and ALLAY-HFrEF clinical trials: CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only. #HeartFailure #InterventionalCardiology #StructuralHeart #InterventionalHeartFailure #ClinicalResearch #HFpEF #HFrEF #Cardiology #HeartFailureAwareness #Epeeps

Many people with chronic heart failure experience pressure buildup inside the heart, which contributes to symptoms such as shortness of breath and fatigue. Interatrial shunting is an investigational device-based approach designed to relieve the excess pressure. The goal: create a small pathway or "pressure relief valve" for blood to flow from a higher-pressure chamber to a lower-pressure chamber within the heart. Researchers are currently evaluating this approach in the ALLAY-HF and ALLAY-HFrEF clinical trials. Watch Dr. James Udelson explain the science behind this investigational procedure. CAUTION – Investigational device. Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only. #HeartFailure #InterventionalCardiology #StructuralHeart #InterventionalHeartFailure #ClinicalResearch #HFpEF #HFrEF #Cardiology #HeartFailureAwareness

May-June moments from across the global #ALLAYHF network: A look back at some of the teams helping build momentum in the ALLAY-HF trial program. Congratulations to all our global sites with summer randomizations! Uniwersytecki Szpital Kliniczny (@USK_Wroclaw) Southlake Health (@southlakehlth) Centre hospitalier de l’Universite de Montreal (CHUM) (@chumontreal) Silesian Center for Heart Diseases (@SCCS_Zabrze) Boston University Medical Center (@The_BMC) Dunedin Hospital (@TeWhatuOra) Washington University St. Louis (@washumedicine) Tennova Healthcare - Turkey Creek Medical Center (@TennovaHealth) Duke University Medical Center (@DukeHealth, @DukeHospital) Scripps Health (@ScrippsHealth) Johns Hopkins Medical Institution (@HopkinsMedicine) Kardiocentrum Nemocnice AGEL Třinec-Podlesi Hospital Universitario Puerta de Hierro (@HospiPtaHierro) Waco Cardiology (@WacoCardiologya) INCLIVA Hospital Clinico Universitario de Valencia (@incliva_iis) Minneapolis Heart Institute Foundation (@MHIF_Heart) #AtrialShunt #HeartFailure #InterventionalCardiology #StructuralHeart #InterventionalHeartFailure #ClinicalResearch #HFpEF #Cardiology #HeartFailureAwareness

Congratulations to PI Dr. Marta Cobo Marcos (@MartaCoboMarcos) and the research team at Hospital Universitario Puerta de Hierro (@HospiPtaHierro) on their first #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology

Congratulations to PI Prof. Marisa Crespo Leiro (@MG_Crespo_Leiro) and the research team at Hospital Universitario A Coruna (@SanidadeACoruna) on their first #ALLAYHFrEF randomization! #atrialshunt #HFrEF #heartfailure #structuralheart #interventionalcardiology